Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinically Precedented Protein Kinases: Rationale for Their Use in Neurodegenerative Disease

2 Sept 2020

Abstract excerpt

Kinases are an intensively studied drug target class in current pharmacological research as evidenced by the large number of kinase inhibitors being assessed in clinical trials. Kinase-targeted therapies have potential for treatment of a broad array of indications including central nervous system (CNS) disorders. In addition to the many variables which contribute to identification of a successful therapeutic...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alzheimer's disease research and treatments
Share to Cholinesterase and Neurodegenerative Diseases
Share to Nuclear Receptors and Signaling

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 33117143
DOI: 10.3389/fnagi.2020.00242

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinically Precedented Protein Kinases: Rationale for Their Use in Neurodegenerative DiseasePMID 33117143Read ↗

Characterizing the role of the dark kinome in neurodegenerative disease – A mini reviewSemantic proximity Read ↗

Defining the Neural Kinome: Strategies and Opportunities for Small Molecule Drug Discovery to Target Neurodegenerative DiseasesSemantic proximity Read ↗

Protein Kinases and Neurodegenerative DiseasesSemantic proximity Read ↗

Protein Kinases and Parkinson’s DiseaseSemantic proximity Read ↗

Genetic mutations in kinases: a comprehensive review on marketed inhibitors and unexplored targets in Parkinson's diseaseSemantic proximity Read ↗

Targeting dementias through cancer kinases inhibitionSemantic proximity Read ↗

Kinase Inhibitors and Kinase-Targeted Cancer Therapies: Recent Advances and Future PerspectivesSemantic proximity Read ↗

GSK-3β, FYN, and DYRK1A: Master Regulators in Neurodegenerative PathwaysSemantic proximity Read ↗

CK2 and protein kinases of the CK1 superfamily as targets for neurodegenerative disordersSemantic proximity Read ↗

Cdk5: a multifaceted kinase in neurodegenerative diseasesSemantic proximity Read ↗

The multifaceted role of kinases in amyotrophic lateral sclerosis: genetic, pathological and therapeutic implicationsSemantic proximity Read ↗

Leucine Rich Repeat Kinase 2: beyond Parkinson's and beyond kinase inhibitors.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.